Pasar al contenido principal

ESTUDIO DE LA TOXICIDAD MITOCONDRIAL EN RECIEN NACIDOS Y LACTANTES CON INFECCION CONGENITA POR CITOMEGALOVIRUS TRATADOS CON GANCICLOVIR O VALGANCICLOVIR.

PI17/00359

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2017
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARA LA INVESTIGACION Y DOCENCIA SANT JOAN DE DEU
Centro realización HOSPITAL SAN JUAN DE DIOS ESPLUGUES

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Mitocentric View of the Main Bacterial and Parasitic Infectious Diseases in the Pediatric Population

  • Romero-Cordero, Sonia
  • Kirwan, Richard
  • Noguera-Julian, Antoni|||0000-0001-7485-0583
  • Cardellach, Francesc|||0000-0003-3286-3436
  • Fortuny Guasch, Claudia
  • Morén, Constanza|||0000-0001-6848-7407
Infectious diseases occur worldwide with great frequency in both adults and children. Both infections and their treatments trigger mitochondrial interactions at multiple levels: (i) incorporation of damaged or mutated proteins to the complexes of the electron transport chain, (ii) mitochondrial genome (depletion, deletions, and point mutations) and mitochondrial dynamics (fusion and fission), (iii) membrane potential, (iv) apoptotic regulation, (v) generation of reactive oxygen species, among others. Such alterations may result in serious adverse clinical events with great impact on children's quality of life, even resulting in death. As such, bacterial agents are frequently associated with loss of mitochondrial membrane potential and cytochrome c release, ultimately leading to mitochondrial apoptosis by activation of caspases-3 and -9. Using Rayyan QCRI software for systematic reviews, we explore the association between mitochondrial alterations and pediatric infections including (i) bacterial: M. tuberculosis, E. cloacae, P. mirabilis, E. coli, S. enterica, S. aureus, S. pneumoniae, N. meningitidis and (ii) parasitic: P. falciparum. We analyze how these pediatric infections and their treatments may lead to mitochondrial deterioration in this especially vulnerable population, with the intention of improving both the understanding of these diseases and their management in clinical practice.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Multicentric Standardization of Protocols for the Diagnosis of Human Mitochondrial Respiratory Chain Defects

  • Bujan, Nuria
  • Morén, Constanza|||0000-0001-6848-7407
  • García García, Francesc Josep|||0000-0001-9021-0324
  • Blázquez, Alberto|||0000-0002-6479-3615
  • Carnicer, Clara
  • Cortés Rodríguez, Ana Belén|||0000-0003-0675-6485
  • González, Cristina
  • López-Gallardo, Ester
  • Lozano, Ester|||0000-0002-6307-9807
  • Moliner, Sonia
  • Gort, Laura|||0000-0003-4746-1034
  • Tobías, Ester|||0000-0002-9968-3651
  • Delmiro, Aitor
  • Martín, Miguel A.|||0000-0003-4741-772X
  • Fernández-Moreno, Miguel Ángel|||0000-0002-3461-0726
  • Ruiz-Pesini, Eduardo|||0000-0002-0269-7337
  • García Arumí, Elena|||0000-0003-1848-005X
  • Rodríguez Aguilera, Juan Carlos|||0000-0002-3371-4128
  • Garrabou, Glòria|||0000-0001-8973-9933
The quantification of mitochondrial respiratory chain (MRC) enzymatic activities is essential for diagnosis of a wide range of mitochondrial diseases, ranging from inherited defects to secondary dysfunctions. MRC lesion is frequently linked to extended cell damage through the generation of proton leak or oxidative stress, threatening organ viability and patient health. However, the intrinsic challenge of a methodological setup and the high variability in measuring MRC enzymatic activities represents a major obstacle for comparative analysis amongst institutions. To improve experimental and statistical robustness, seven Spanish centers with extensive experience in mitochondrial research and diagnosis joined to standardize common protocols for spectrophotometric MRC enzymatic measurements using minimum amounts of sample. Herein, we present the detailed protocols, reference ranges, tips and troubleshooting methods for experimental and analytical setups in different sample preparations and tissues that will allow an international standardization of common protocols for the diagnosis of MRC defects. Methodological standardization is a crucial step to obtain comparable reference ranges and international standards for laboratory assays to set the path for further diagnosis and research in the field of mitochondrial diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Assessment of mitochondrial toxicity in newborns and infants with congenital cytomegalovirus infection treated with valganciclovir

  • Ortiz-Gracia, Alba|||0000-0003-2330-7235
  • Ríos, María
  • Tobías, Ester|||0000-0002-9968-3651
  • Noguera-Julian, Antoni|||0000-0001-7485-0583
  • García García, Francesc Josep|||0000-0001-9021-0324
  • Cantó-Santos, Judith|||0000-0002-0272-7014
  • Valls-Roca, Laura|||0000-0001-5956-6752
  • Garrabou, Glòria|||0000-0001-8973-9933
  • Grau, Josep M.|||0000-0001-7560-224X
  • Cardellach, Francesc|||0000-0003-3286-3436
  • Sánchez, Emilia
  • Morén, Constanza|||0000-0001-6848-7407
  • Fortuny Guasch, Claudia
Ganciclovir/valganciclovir is currently indicated during the first 6 months of life in symptomatic children with congenital cytomegalovirus (CMV) infection. However, this treatment may have the potential to induce mitochondrial toxicity due to off-target inhibition of DNA-polymerases. Similar anti-HIV drugs have been associated with mitochondrial toxicity but this has never been explored in CMV. To determine the potential mitochondrial toxicity profile at the genetic, functional and biogenesis level in peripheral blood mononuclear cells from a cohort of newborns and infants with symptomatic congenital CMV infection (treated with valganciclovir, untreated and uninfected controls). Longitudinal, observational and controlled study. Subjects were recruited at the tertiary referral Hospital Sant Joan de Déu and experiments were conducted at IDIBAPS-Hospital Clínic of Barcelona, Spain. CMV-infected newborns underwent comprehensive monthly clinical follow-up. Mitochondrial parameters, audiometry and neurological assessment were measured at baseline, 3-6 and 12 months after inclusion in the study. The Kruskal-Wallis test for k-independent samples and Friedman tests for repeated measurements were applied. Complex IV, citrate synthase enzymatic activities and mtDNA remained preserved in congenital CMV-infected infants treated with valganciclovir compared with controls (p.